# Quetiapine for Bipolar Disorder and Alcohol Dependence

> **NCT00457197** · PHASE4 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 90 (actual)

## Conditions studied

- Bipolar Disorder
- Alcohol Dependence

## Interventions

- **DRUG:** Placebo
- **DRUG:** Quetiapine

## Key facts

- **NCT ID:** NCT00457197
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00457197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00457197, "Quetiapine for Bipolar Disorder and Alcohol Dependence". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00457197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*